Using simple models to describe the kinetics of growth, glucose consumption, and monoclonal antibody formation in naive and infliximab producer CHO cells
Despite their practical and commercial relevance, there are few reports on the kinetics of growth and production of Chinese hamster ovary (CHO) cells—the most frequently used host for the industrial production of therapeutic proteins. We characterize the kinetics of cell growth, substrate consumptio...
Main Authors: | López-Meza, Julián, Araíz-Hernández, Diana, López-Pacheco, Felipe, Carrillo-Cocom, Leydi Maribel, Rocha-Pizaña, María del Refugio, Alvarez, Mario Moises |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | English |
Published: |
Springer Netherlands
2016
|
Online Access: | http://hdl.handle.net/1721.1/105504 |
Similar Items
-
Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
by: Renato Sablich, et al.
Published: (2023-02-01) -
Adherence patterns in naïve and prevalent use of infliximab and its biosimilar
by: Chibuike J. Alanaeme, et al.
Published: (2022-11-01) -
Stress‐induced increase of monoclonal antibody production in CHO cells
by: Jana Schellenberg, et al.
Published: (2022-05-01) -
“Antimicrobial and antiproliferative activity of essential oil, aqueous and ethanolic extracts of Ocimum micranthum Willd leaves”
by: Isabel O. Caamal-Herrera, et al.
Published: (2018-02-01) -
Medium and feed optimization for fed-batch production of a monoclonal antibody in CHO cells
by: Kochanowski Nadine, et al.
Published: (2011-11-01)